Product Image

Boswellia Phytosome

4.7
★ ★ ★ ★ ★
(907 ratings)
Boswellia 350 mg
Product Image
Score80
Boswellia Phytosome provides focused Boswellia support in a practical format. Total boswellic acids and AKBA are not quantified, while the premium delivery system comes with a high serving cost.
How scoring works
Capsule
Quantity:60 Capsule(s) • (60 servings)
Goals:
Anti-Inflammatory Support
Joint Health

Score 80

Boswellia Phytosome provides focused Boswellia support in a practical format. Total boswellic acids and AKBA are not quantified, while the premium delivery system comes with a high serving cost.
How scoring works
$59.00($0.98 per serving)
iHerb
$ 59.00
Pure Formulas
$ 59.00
Amazon
$ 59.00
Vitacost
$ 59.00
Report prices

Analysis

Each capsule supplies 350 mg of an Indian frankincense phytosome complex. Phytosome delivery is a meaningful formulation advantage because it is designed to improve absorption.

Boswellia is commonly used to support joint comfort and a normal inflammatory response through its boswellic acids. A focused formula makes that purpose easy to understand, although active-marker disclosure determines how confidently the extract can be compared.

Total boswellic acids and AKBA are not quantified, while the premium delivery system comes with a high serving cost. The 60-serving capsule supply should therefore be judged by active-form clarity and suitability, not just the listed botanical weight.

Who is it for
  • Adults who value enhanced-delivery Boswellia
  • People who prefer supplements in capsule form
  • Users who prefer a clearly focused botanical formula
Best for
  • Absorption-focused Boswellia supplementation
  • Normal inflammatory-response support
  • A routine with 60 servings per container

Pros

  • Phytosome delivery is a meaningful formulation advantage because it is designed to improve absorption
  • 60 servings per container
  • Single-ingredient design keeps the purpose clear

Cons

  • Total boswellic acids and AKBA are not quantified, while the premium delivery system comes with a high serving cost.
  • Single-botanical scope does not cover cartilage structure or joint lubrication.
  • Capsule-only delivery may not suit people who avoid pills.

Warnings

  • Boswellia may add to bleeding tendency with anticoagulant or antiplatelet medicines, so this specific combination warrants medication review.
  • Count other Boswellia products when assessing total daily intake because the active boswellic-acid and AKBA yields may not be fully disclosed.
  • A new rash, digestive upset, or other persistent intolerance after starting Boswellia warrants stopping use and reassessing the product.

Nutrient quality

93 Highest impact

Phytosome delivery and a practical complex amount provide strong formulation quality. Missing active-acid and AKBA yields leave some uncertainty about exact potency.

Ingredient transparency

80 Highest impact

The complex amount and delivery approach are clearly identified without a hidden blend. Missing active yield, full directions, and excipients prevent complete transparency.

Customer satisfaction

71 High impact

The supplied average rating is strong and the rating volume is substantial. No specific experience details were provided to judge repeated complaints or purpose alignment.

Value for money

71 High impact

Enhanced delivery provides a meaningful quality advantage over plain extracts. The relatively high serving cost and unverified active yield temper its category value.

Report analysis

Goals

Anti-Inflammatory Support
Impact
Highest effect
A Goal FitA Strength of SupportC+ CoverageA+ Formula Quality
Boswellia · 350 mg

Boswellia directly targets 5-LOX-related signaling, and the phytosome system is designed to improve absorption. The amount fits a useful extract range, although boswellic-acid and AKBA yields are not disclosed.

Enhanced delivery gives the focused formula strong practical depth in one inflammatory pathway. Boswellia may increase bleeding tendency when combined with anticoagulant or antiplatelet medicines.

Study evidence
Boswellia Supportive 19 studies
Joint Health
Impact
Highest effect
A Goal FitA Strength of SupportC- CoverageA+ Formula Quality
Boswellia · 350 mg

Boswellia directly targets the 5-LOX inflammatory pathway relevant to joint pain and stiffness. Enhanced boswellia extracts have strong human evidence for improving osteoarthritis comfort and function.

The 350 mg phytosome complex reaches a meaningful enhanced-extract range. The phytosome delivery system supports absorption, though boswellic acid and AKBA yields are not stated.

Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per serving
Indian Frankincense Phytosome Complex
350 mg
Gluten Free Adults 18–50
Report overview
Boswellia · 350 mg OverallScore56
F Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyD- Value

The phytosome delivery system is a meaningful strength for absorption of boswellic acids. Its amount fits the standard-extract clinical range, although neither total boswellic acids nor AKBA is quantified. The premium delivery comes at a relatively high serving cost.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
    Dalmonte T; Andreani G; Rudelli C; Isani G · Phytotherapy research : PTR · 2024
    Meta-analysis1,185 participants13 studies pooledJoint Health forBoswellia
  2. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W · Inflammatory bowel diseases · 2011
    Randomized trial108 participantsAnti-Inflammatory Support forBoswellia
  3. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee.
    Kulkarni PD; Damle ND; Singh S; Yadav KS; Ghante MR; Bhaskar VH; Hingorani L; Gota VS · Drug metabolism and personalized therapy · 2021
    Randomized trialAnti-Inflammatory Support forBoswellia
  4. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsJoint Health Anti-Inflammatory Support forBoswellia
  5. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsJoint Health Anti-Inflammatory Support forBoswellia
  6. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  7. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  8. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support Joint Health forBoswellia
  9. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health Anti-Inflammatory Support forBoswellia
  10. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  11. Efficacy and Safety of Aflapin®, a Novel Boswellia Serrata Extract, in the Treatment of Osteoarthritis of the Knee: A Short-Term 30-Day Randomized, Double-Blind, Placebo-Controlled Clinical Study.
    Karlapudi V; Sunkara KB; Konda PR; Sarma KV; Rokkam MP · Journal of the American Nutrition Association · 2023
    Randomized trial70 participantsJoint Health forBoswellia
  12. Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis.
    Zhang Y; Gui Y; Adams R; Farragher J; Itsiopoulos C; Bow K; Cai M; Han J · Nutrients · 2025
    Meta-analysis4,599 participants39 studies pooledJoint Health forBoswellia
  13. Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis.
    Bannuru RR; Osani MC; Al-Eid F; Wang C · Seminars in arthritis and rheumatism · 2019
    Meta-analysis1,009 participants11 studies pooledJoint Health forBoswellia
  14. A full-spectrum Boswellia serrata extract with enhanced bioavailability, and its co-delivered system with curcumin alleviate pain and stiffness associated with moderate spondylitis: a randomized double-blind, placebo-controlled, 3-arm study.
    Mamatha K; Prabhakaran P; Syam Das S; Kanjoormana Aryan M; Thomas J · Frontiers in pharmacology · 2025
    Randomized trial105 participantsAnti-Inflammatory Support forBoswellia
  15. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study.
    Sengupta K; Krishnaraju AV; Vishal AA; Mishra A; Trimurtulu G; Sarma KV; Raychaudhuri SK; Raychaudhuri SP · International journal of medical sciences · 2011
    Randomized trial60 participantsJoint Health forBoswellia
  16. Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities.
    Efferth T; Oesch F · Seminars in cancer biology · 2022
    Systematic reviewAnti-Inflammatory Support forBoswellia
  17. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia